Adagio Medical Holdings (ADGM) EBT Margin (2023 - 2024)
Adagio Medical Holdings' (ADGM) quarterly EBT Margin came in at 3556.06% in Q3 2024, up 1977077.0% year-over-year from N/an in Q4 2023, and down 21.78% quarter-over-quarter from 2920.08% in Q2 2024.
Powered by 
Analysis
Adagio Medical Holdings (ADGM) EBT Margin (2023 - 2024) Analysis & Trends
Adagio Medical Holdings has disclosed EBT Margin across 2 years of filings, most recently posting 3556.06% for Q3 2024.
- In Q3 2024, EBT Margin rose 1977077.0% year-over-year to 3556.06%; the TTM figure through Sep 2025 stood at 18420.45% (down 1279025.0% YoY), while the FY2024 annual figure was 23481.41%, down 1361541.0% from the prior year.
- EBT Margin came in at 3556.06% for Q3 2024 at Adagio Medical Holdings, down from 2920.08% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 2920.08% in Q2 2024 to a low of 36800.0% in Q1 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.02 Bn | 176.42 Bn | 7.27 Bn | 12.10% |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 36.46% |
| 3 | Medtronic | 117.91 Bn | 109.10 Bn | 6.34 Bn | 18.13% |
| 4 | Stryker | 105.64 Bn | 102.17 Bn | 4.50 Bn | 23.74% |
| 5 | Boston Scientific | 64.99 Bn | 64.45 Bn | 3.85 Bn | 19.48% |
| 6 | Edwards Lifesciences | 49.92 Bn | 45.67 Bn | 1.35 Bn | 29.86% |
| 7 | Alcon | 33.23 Bn | 31.78 Bn | 1.68 Bn | -1.65% |
| 8 | Dexcom | 32.10 Bn | 30.16 Bn | 830.00 Mn | 24.27% |
| 9 | Steris | 20.83 Bn | 20.35 Bn | 684.20 Mn | 18.32% |
| 10 | Adagio Medical Holdings | 12.88 Mn | 12.88 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2024 | -3,556.06% |
| Jun 30, 2024 | -2,920.08% |
| Mar 31, 2024 | -36,800.00% |
| Dec 31, 2023 | -7,575.64% |
| Sep 30, 2023 | -23,326.83% |